AEON Biopharma Inc (AEON) Price
AEON Stock Price Chart
AEON Financial
AEON Biopharma Inc
$0.93
3.12%
$0.02
$0.93
0.42%
$0
Income
Balance sheet
Cash flow
Annual
Quarterly
AEON Income
Financials in millions USD. Fiscal year is February - January.
| Breakdown | TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Selling, General & Admin | 12 | 13 | 19 | 13 | 11 |
| Research & Development | 5 | 14 | 33 | 34 | 25 |
| Operating Expenses | 11 | -72 | 0 | 48 | 36 |
| Other Non Operating Income (Expenses) | 11 | -14 | 2 | 0 | 0 |
| Pretax Income | -1 | 42 | -384 | -52 | -55 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | -1 | 42 | -384 | -52 | -55 |
| Net Income Growth | -100% | -111% | 638% | -5% | -- |
| Shares Outstanding (Diluted) | 11.09 | 0.57 | 0.51 | 0.51 | 0.51 |
| Shares Change (YoY) | 1,955.99% | 12% | 0% | 0% | -- |
| EPS (Diluted) | -0.14 | 72.93 | -745.25 | -101.83 | -107.8 |
| EPS Growth | -100% | -110% | 632% | -6% | -- |
| Free Cash Flow | -13 | -20 | -47 | -35 | -28 |
| Free Cash Flow Per Share | -1.17 | -34.72 | -91.06 | -67.81 | -54.25 |
| Gross Margin | -- | -- | -- | -- | -- |
| Operating Margin | 0% | 0% | 0% | 0% | 0% |
| Profit Margin | 0% | 0% | 0% | 0% | 0% |
| Free Cash Flow Margin | 0% | 0% | 0% | 0% | 0% |
| EBITDA | -11 | 72 | 0 | -48 | -36 |
| EBITDA Margin | 0% | 0% | 0% | 0% | 0% |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 |
| EBIT | -11 | 72 | 0 | -48 | -36 |
| EBIT Margin | 0% | 0% | 0% | 0% | 0% |
| Effective Tax Rate | 0% | 0% | 0% | 0% | 0% |
Follow-Up Questions
AEON Biopharma Inc 的关键财务报表是什么？
AEON 的关键财务比率是什么？
AEON Biopharma Inc 的收入按细分市场或地理位置如何划分？
AEON Biopharma Inc 是否盈利？
AEON Biopharma Inc 有负债吗？
AEON Biopharma Inc 的流通股有多少？
Features
Trading Strategies
Resources
© 2025 Edgen Powered by
Ask AI About AEON